ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Predict the Benefit of ADT in Localized Prostate Cancer With Validation in NRG/RTOG 9408
By
ASCO Genitourinary Cancers Symposium
FEATURING
Daniel Spratt
By
ASCO Genitourinary Cancers Symposium
FEATURING
Daniel Spratt
43 views
March 14, 2022
Login to view comments.
Click here to Login
Videos